Literature DB >> 1764388

LHRH analogues and breast cancer.

E Korkut, A M Comaru-Schally, A V Schally, P N Plowman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1764388      PMCID： PMC1977846          DOI： 10.1038/bjc.1991.490

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues.

Authors:  S Bajusz; V J Csernus; T Janaky; L Bokser; M Fekete; A V Schally
Journal:  Int J Pept Protein Res       Date:  1988-12

2.  Endocrine therapy of advanced breast cancer.

Authors:  C Rose; H T Mouridsen
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

3.  Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75.

Authors:  B Szende; G Srkalovic; K Groot; K Lapis; A V Schally
Journal:  J Natl Cancer Inst       Date:  1990-03-21       Impact factor: 13.506

4.  Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.

Authors:  T Fornander; L E Rutqvist; B Cedermark; U Glas; A Mattsson; C Silfverswärd; L Skoog; A Somell; T Theve; N Wilking
Journal:  Lancet       Date:  1989-01-21       Impact factor: 79.321

5.  A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.

Authors:  R B Buchanan; R W Blamey; K R Durrant; A Howell; A G Paterson; P E Preece; D C Smith; C J Williams; R G Wilson
Journal:  J Clin Oncol       Date:  1986-09       Impact factor: 44.544

6.  Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.

Authors:  J N Ingle; J E Krook; S J Green; T P Kubista; L K Everson; D L Ahmann; M N Chang; H F Bisel; H E Windschitl; D I Twito
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

7.  Response of advanced breast cancer to total endocrine ablation after exacerbation on tamoxifen: results in seven patients and possible mechanism of action.

Authors:  J W Hartley; J Wong; W S Fletcher
Journal:  J Surg Oncol       Date:  1987-03       Impact factor: 3.454

8.  Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone.

Authors:  Y Sharoni; E Bosin; A Miinster; J Levy; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  LHRH analogues in breast cancer: clever, but do we need them?

Authors:  I E Smith
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.